Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Parkinson's Disease

  Free Subscription


09.05.2022

1 Exp Neurol
1 J Neural Transm (Vienna)
2 J Neurol Neurosurg Psychiatry
1 J Neurosci
6 Mov Disord
1 Neuropsychology
2 Neurosci Lett
1 PLoS Biol
3 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Exp Neurol

  1. WIEST C, Torrecillos F, Tinkhauser G, Pogosyan A, et al
    Finely-tuned gamma oscillations: Spectral characteristics and links to dyskinesia.
    Exp Neurol. 2022;351:113999.
    PubMed         Abstract available


    J Neural Transm (Vienna)

  2. LAU YH, Leta V, Rukavina K, Parry M, et al
    Tolerability of overnight rotigotine transdermal patch combined with intrajejunal levodopa infusion at 1 year: a 24-h treatment option in Parkinson's disease.
    J Neural Transm (Vienna). 2022 May 3. pii: 10.1007/s00702-022-02506.
    PubMed         Abstract available


    J Neurol Neurosurg Psychiatry

  3. WANG C, Chen F, Li Y, Liu J, et al
    Possible predictors of phenoconversion in isolated REM sleep behaviour disorder: a systematic review and meta-analysis.
    J Neurol Neurosurg Psychiatry. 2022;93:395-403.
    PubMed         Abstract available

  4. HALBGEBAUER S, Oeckl P, Steinacker P, Yilmazer-Hanke D, et al
    Beta-synuclein in cerebrospinal fluid as an early diagnostic marker of Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2020 Dec 30. pii: jnnp-2020-324306.
    PubMed         Abstract available


    J Neurosci

  5. XU X, He X, Zhang Z, Chen Y, et al
    CREB inactivation by HDAC1/PP1gamma contributes to dopaminergic neurodegeneration in Parkinson's disease.
    J Neurosci. 2022 Apr 29. pii: JNEUROSCI.1419-21.2022.
    PubMed         Abstract available


    Mov Disord

  6. JANZEN A, Kogan RV, Meles SK, Sittig E, et al
    Rapid Eye Movement Sleep Behavior Disorder: Abnormal Cardiac Image and Progressive Abnormal Metabolic Brain Pattern.
    Mov Disord. 2022;37:624-629.
    PubMed         Abstract available

  7. ROEDIGER J, Dembek TA, Wenzel G, Butenko K, et al
    StimFit-A Data-Driven Algorithm for Automated Deep Brain Stimulation Programming.
    Mov Disord. 2022;37:574-584.
    PubMed         Abstract available

  8. LINARD M, Ravier A, Mougue L, Grgurina I, et al
    Infectious Agents as Potential Drivers of alpha-Synucleinopathies.
    Mov Disord. 2022;37:464-477.
    PubMed         Abstract available

  9. BANDRES-CIGA S
    Black and African American Connections to Parkinson's Disease Study: Addressing Missing Diversity in Parkinson's Disease Genetics.
    Mov Disord. 2022 Apr 30. doi: 10.1002/mds.29042.
    PubMed        

  10. STEINHARDT J, Hanssen H, Heldmann M, Sprenger A, et al
    Prodromal X-Linked Dystonia-Parkinsonism is Characterized by a Subclinical Motor Phenotype.
    Mov Disord. 2022 May 2. doi: 10.1002/mds.29033.
    PubMed         Abstract available

  11. ZHOU X, Liu Z, Zhou X, Xiang Y, et al
    The Chinese Parkinson's Disease Registry (CPDR): Study Design and Baseline Patient Characteristics.
    Mov Disord. 2022 May 3. doi: 10.1002/mds.29037.
    PubMed         Abstract available


    Neuropsychology

  12. SIQUIER A, Andres P
    Facial emotion recognition in Parkinson's disease: The role of executive and affective domains.
    Neuropsychology. 2022 May 5. pii: 2022-58801-001. doi: 10.1037/neu0000814.
    PubMed         Abstract available


    Neurosci Lett

  13. ZHANG J, Wang M, Zhao Y, Zhang Y, et al
    Alpha-lipoic acid improved motor function in MPTP-induced Parkinsonian mice by reducing neuroinflammation in the nigral and spinal cord.
    Neurosci Lett. 2022;781:136669.
    PubMed         Abstract available

  14. LIM HS, Park G
    Resilin, an insect-derived elastomeric protein, protects dopaminergic neurons in Parkinson disease models.
    Neurosci Lett. 2022;781:136667.
    PubMed         Abstract available


    PLoS Biol

  15. MAMAIS A, Kluss JH, Bonet-Ponce L, Landeck N, et al
    Correction: Mutations in LRRK2 linked to Parkinson disease sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microglia.
    PLoS Biol. 2022;20:e3001621.
    PubMed         Abstract available


    PLoS One

  16. VIRBEL-FLEISCHMAN C, Retory Y, Hardy S, Huiban C, et al
    Body-Worn Sensors for Parkinson's disease: A qualitative approach with patients and healthcare professionals.
    PLoS One. 2022;17:e0265438.
    PubMed         Abstract available

  17. BAKKER M, Johnson ME, Corre L, Mill DN, et al
    Identifying rates and risk factors for medication errors during hospitalization in the Australian Parkinson's disease population: A 3-year, multi-center study.
    PLoS One. 2022;17:e0267969.
    PubMed         Abstract available

  18. MEDINA CA, Vargas E, Munger SJ, Miller JE, et al
    Vocal changes in a zebra finch model of Parkinson's disease characterized by alpha-synuclein overexpression in the song-dedicated anterior forebrain pathway.
    PLoS One. 2022;17:e0265604.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  19. ADAM EM, Brown EN, Kopell N, McCarthy MM, et al
    Deep brain stimulation in the subthalamic nucleus for Parkinson's disease can restore dynamics of striatal networks.
    Proc Natl Acad Sci U S A. 2022;119:e2120808119.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: